Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

PMGC Holdings Inc. - Common Stock (NQ: ELAB )

3.920 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PMGC Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity Symposium
Northstrive Biosciences Inc. was invited to present EL-22, a novel myostatin asset aimed at preserving muscle while on weight loss treatments, at the UCLA Obesity Symposium called Anti-Obesity... 
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture
Strategic Divestment Reduces Cash Burn and Enhances Operational Efficiency 
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy
From PMGC Holdings Inc.
Via GlobeNewswire
Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
From PMGC Holdings Inc.
Via GlobeNewswire
Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada
From Elevai Labs Inc.
Via GlobeNewswire
Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada
From Elevai Labs Inc.
Via GlobeNewswire
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Announces FDA Regulatory Pathway for EL-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle Preservation
From Elevai Labs Inc.
Via GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market
From Elevai Labs Inc.
Via GlobeNewswire
Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division
From Elevai Labs Inc.
Via GlobeNewswire
Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance
From Elevai Labs Inc.
Via GlobeNewswire
Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess
From Elevai Labs Inc.
Via GlobeNewswire
CORRECTION - Elevai Labs Inc.
From Elevai Labs Inc.
Via GlobeNewswire
US Stocks Edge Lower; Cisco Earnings Top Views
Via Benzinga
Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update
From Elevai Labs Inc.
Via GlobeNewswire
Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
MicroCaps Making Major Moves: DJT, BNOX, ELAB, PETV, RJDG in High-Growth Markets
Via AB Newswire
Topics Government
Exposures Political
Why Palantir Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange
From Elevai Labs Inc.
Via GlobeNewswire
Dow Jumps 400 Points; US Adds 12,000 Jobs In October
Via Benzinga
Topics Stocks
Exposures US Equities
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Consumer Staples Stocks Moving In Friday's Intraday Session
Via Benzinga
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity
From Elevai Labs Inc.
Via GlobeNewswire
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity
From Elevai Labs Inc.
Via GlobeNewswire
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
Via Benzinga
Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock
From Elevai Labs Inc.
Via GlobeNewswire
12 Consumer Staples Stocks Moving In Friday's After-Market Session
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.